• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGU343420
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 05/31/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the manufacturing records indicated the lot met pre-release specifications.According to the conformable gore® tag® thoracic endoprosthesis instructions for use (ifu), complications associated with the use of the conformable gore® tag® thoracic endoprosthesis may include but are not limited to aneurysm enlargement and reoperation.
 
Event or Problem Description
The following information was reported to gore: on (b)(6) 2017, the patient underwent treatment of a 32 cm (total treatment length) descending thoracic aortic (zone 2) dissection, distal to the left common carotid artery ostium and proximal to the left subclavian artery (lsa) with a conformable gore® tag® thoracic endoprosthesis (tgu343420/(b)(4)) and two gore® tag® thoracic branch endoprostheses (tac123420c/(b)(4) and tsb121506c/(b)(4)).According to the report, the left subclavian artery (lsa) was the intended branch vessel to be treated.On (b)(6) 2018 the thoracoabdominal aneurysm was reportedly enlarging, from chronic aneurysmal degeneration of a debakey type i dissection.On (b)(6) 2018 an abdominal aortic stent graft placement was performed to treat the enlarging thoracoabdominal aneurysm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG)
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key7632593
Report Number2017233-2018-00334
Device Sequence Number2281516
Product Code MIH
UDI-Device Identifier00733132618170
UDI-Public00733132618170
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P040043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source study
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/01/2020
Device Catalogue NumberTGU343420
Device Lot Number16359553
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date06/23/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Other; Required Intervention;
Patient Age61 YR
Patient Weight101
-
-